Stock recommendations by brokers for March 19 – The Times of India
ICICI Securities has a ‘buy’ rating on Akums Drugs & Pharmaceuticals with a target price of Rs 710. Analysts said that the company is aiming for profitable growth ahead. And the company has been able to maintain its CDMO and overall EBITDA margin at 15.5%/12.0% despite its sub-par revenue growth so far in FY25. Further…